SHPH Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SHPH shares is 7, representing 1.81% of the company's common stock.

VIRTU FINANCIAL LLC, in the last quarter, reduced its stake in SHPH by -48.22% restricting it's holding to 10.48 thousand shares of worth nearly $4.00K. RENAISSANCE TECHNOLOGIES LLC also lessened -41.9% of the SHPH shares from its portfolio, reducing its holding to 16.5 thousand shares of worth $7.00K. STONEX GROUP INC. also shunned SHPH shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, UBS GROUP AG increased its stake in SHPH by 100% in the last quarter. The institutional holder raised its holding to 1.12 thousand shares having worth more than $455.00. FEDERATION DES CAISSES DESJARDINS DU QUEBEC also added 100% more shares of SHPH to its portfolio, raising its holding to 500 shares of worth $203.00. TOWER RESEARCH CAPITAL LLC (TRC) also increased its SHPH shares holding by 151% which brought its holding to 251 shares worth $102.00.

The insider with the most stakes in SHPH is Brown Milton , director at the company. Additionally, SHPH stock is highly held by CEO and Chairman Dritschilo Anatoly and Chief Scientific Officer Jung Mira among others.

Company executives, directors, and other insiders own 27.82% percent of Shuttle Pharmaceuticals Holdings, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which SHPH insiders have sold stock, totaling 0 shares. Insiders that have sold shares include JACOBS BETTE, BROWN MILTON, and ADKINS WILLIAM.

There have been 0 transaction(s) during the past 6-months in which Shuttle Pharmaceuticals Holdings, Inc. insiders have bought stock, totalling 0 shares

Around 0 Shuttle Pharmaceuticals Holdings, Inc. shares are held by insiders, which represents about 27.82% of SHPH stock.

SHPH director, Brown Milton holds the largest portfolio of the company's shares. SHPH shares owned by Brown total nearly 1.09 million.

UBS GROUP AG is the largest institutional owner in SHPH which holds 1.12 thousand shares worth $455.00 or 0.01% of the total SHPH shares outstanding followed by VIRTU FINANCIAL LLC with ownership of 10.48 thousand shares representing 0.07% of the SHPH ownership. FEDERATION DES CAISSES DESJARDINS DU QUEBEC is the third largest stakeholder with 500 shares or 0% of the ownership worth more than $203.00.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SHPH is concerned, it is a stock which is not optionable.

Number of SHPH shares short is 702.63K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 4.08M shares of SHPH are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SHPH has 1.38M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SHPH is 0.25.